Clinical Trial Update: Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

View source ↗

Summary

Clinical trial update evaluating whether the 3D-PANC MSP model better assesses neoadjuvant treatment response in pancreatic adenocarcinoma than current CT imagi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Adenocarcinoma of the Pancreas | Status: RECRUITING